The cleavage of an intracellular 67,000-to 70,000-dalton precursor, termed Pr4, to Rauscher leukemia virus (RLV) p30 protein proceeded at a slower rate when virus-producing cells were treated with actinomycin D (AMD). Treatment with AMD also caused a slight accumulation of Pr4 in purified early virus particles produced by a cell line which usually produces virions that contain little Pr4. The cleavage of other intracellular viral precursor polypeptides was not affected by treatment with AMD. Treatment of infected cells with cycloheximide, on the other hand, allowed the cleavage of Pr4 to proceed at the usual rate for a short period of time before further cleavage was drastically slowed or prevented. The cleavage of several other viral precursor polypeptides was also inhibited by treatment with cycloheximide. Different lines of evidence suggest that the mechanism of action of AMD is not due to a possible indirect effect on protein synthesis. Thus, the rate of cleavage of Pr4 was not affected by the length of pretreatment with AMD between 1 to 8 h. In addition, the combined effect of AMD and cycloheximide, at their maximal inhibitory concentrations, was greater than the effect of either drug alone, indicating the involvement of two at least partially different mechanisms in the action of AMD and cycloheximide. Furthermore, AMD did not affect the pulse labeling of viral precursor polypeptides. These results suggest that the interaction with viral RNA, whose production is inhibited by AMD, accelerates the cleavage of Pr4 to p30 during virus assembly. A hypothetical model is presented to illustrate the possible advantages of having a step in virus assembly in which genomic RNA interacts with a precursor to capsid proteins before the cleavage of that precursor.
small quantities in infected cell extracts, are larger precursors with a molecular weight of about 200,000, designated Prla+b (2) .
The effect of actinomycin D (AMD) on the inhibition of oncornaviral RNA synthesis is well established (4, 10, 33, 50) . Treatment of virus-producing cells with AMD, however, allows for several hours the synthesis of viral proteins and the maturation of RNA-deficient viral particles that have normal morphology (33) . Thus, treatment with AMD makes it possible to examine the role of genomic RNA in the maturation and processing of the viral proteins during virus assembly.
In this paper, we describe the observation that treatment of chronically infected cells with AMD noticeably slowed the rate of cleavage of Pr4 and caused its accumulation in infected cells and, to a small extent, in early virus particles. Pr4, previously designated p70, is an intermediate intracellular precursor polypeptide, but is present in mature virions produced by several infected cell lines (24) . (49) were used in this study. The culture medium contained a modified Eagle amino acid formula and 10% fetal calf serum, as described previously (49) . Cells were grown in 2-ounce (about 60-ml) prescription glass bottles or, for virus production, in l-quart (about 0.95-liter) glass bottles. The cultures were used 3 to 6 days after passage and were nearly confluent.
MATERIALS AND METHODS Cells and virus. RLV-infected NIH Swiss mouse embryo (JLS-V16) (37) and RLV-infected BALB/c mouse spleen and thymus cells (JLS-V5)
For virus purification, culture fluid was collected and clarified at 10,000 x g for 10 min. The virus was pelleted at 78,000 x g for 2 h, suspended in TNE buffer (0.01 M Tris, pH 7.5, 0.1 M NaCl, 0.001 M EDTA), and banded by isopycnic centrifugation on a 15 to 60% (wt/vol) sucrose gradient in TNE for 16 h at 13 ,000 rpm in a Beckman SW27 rotor. To recover cell-associated viral particles, the cell sheet was rinsed with rinsing buffer (0.14 M NaCl, 5 mM KCl, 0.3 mM Na2,HPO47H20, 0.4 mM KH2PO4, 5.5 mM glucose, 4 mM NaHCO3, 100 mg of neomycin per liter) and treated for 5 min with 0.02% trypsin in rinsing buffer. The resultant cell suspension was pooled with the culture fluid, and the cells were pelleted. The supernatant fluids were processed for virus purification as described above. The sucrose gradients were fractionated into 1-ml portions, and trichloroacetic acid-insoluble radioactivity and density were measured. The radioactivity peak at densities of 1.13 to 1.16 g/cm3 was pooled, diluted in TNE, and pelleted at 78,000 x g for 2 h.
Labeling of cells and virus. Labeling of cells for pulse-chase studies was done as follows: the cells were rinsed with warm Hanks solution and labeled in Hanks solution containing 100 ACi of [35S]methionine per ml (288 Ci/mmol; Amersham/ Searle) or in complete growth medium (49) minus methionine containing 5% dialyzed fetal calf serum and no tryptose phosphate. The pattern of radioactive proteins was identical in either case. For a chase, the cells were rinsed with Hanks solution and incubated in complete growth medium. For virus labeling, the cells were rinsed with Hanks solution and incubated for 4 h in growth medium which contained 45 ,MCi of [35S]methionine per ml, 1/10 Eagle's concentration of unlabeled methionine, 5% dialyzed fetal calf serum, and no tryptose phosphate.
Immunoprecipitation and gel electrophoresis. Cell lysis, the preparation of anti-RLV antiserum, and the immunoprecipitation of virus-specific proteins in infected cell lysates were described previously (37) . Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis of proteins was done by using the buffer system described by Laemmli (28) ; RNA urea-acrylamide-agarose gel electrophoresis was done as described by Floyd et al. (17) except that SDS was used instead of lithium dodecyl sulfate, and electrophoresis was at room temperature. The gels were processed for fluorography as described by Bonner and Laskey (6) . To obtain a linear response to radioactivity, the X-ray films were preflashed (32) . To quantitate the amount of radioactivity in different bands, the films were scanned at 590 nm in a Gilford spectrophotometer, and the relative areas of different peaks in the resulting curves were measured in a DuPont 310 curve resolver.
RESULTS
Effect of AMD on viral RNA and protein synthesis in chronically infected cells. Inhibition of oncornaviral RNA synthesis by treatment with AMD occurs rapidly (e.g., reference 4). On the other hand, the synthesis of viral proteins and the maturation of RNA-deficient particles in murine leukemia virus-infected cells continues for several hours in the presence of AMD (33) . These two results are shown in Fig. 1 for the RLV-infected JLS-V16 cell line used in these studies. In this experiment, the cells were treated with 5 ,g of AMD per ml for 75 min before they were pulse-labeled for 75 min with medium containing both [H] uridine and [P5S]methionine. After a chase for 3 h in complete medium, the virus was purified on a sucrose gradient and the radioactivity was determined. It can be seen that whereas the [PH]uridine radioactivity was drastically reduced as compared with the control, no significant difference had occurred in the [35Jmethio-nine radioactivity during this period. This result confirms the finding that viral protein synthesis and maturation of viral particles can occur in the absence of viral RNA synthesis (33) , indicating the stability of the viral mRNA for several hours (34) .
We have estimated the rate of synthesis of intracellular virus-specific polypeptides by VOL. 19, 1976 (Fig. 2B, D, F , and H) Pr4 disappeared during a chase period of 3 h at a rate similar to that at which p30 appeared during this period. The fact that Pr4 is a precursor to p30 has been verified by pulse chase studies and tryptic digestion (2) . In AMD-treated cultures ( Fig. 2A, C , E, and G), cleavage of Pr4 to p30 also occurred, but at a much slower rate. Quantitation of the results of Fig. 2 is shown in Fig. 4A as the ratio of p30 to Pr4 obtained at different times of chase in the presence or absence of AMD.
The disappearance of the p30 precursors Prla +b and Pr3 during the chase was also evident in Fig. 2 . However, in contrast to the disappearance of Pr4, the rates at which Prla+b and Pr3 disappeared were similar in AMD-treated and control cultures. This shows that AMD does not affect the cleavage of all viral precursor polypeptides indiscriminately. Dose-response analyses of the effect of AMD on the cleavage of Pr4. The effect of pretreatment with different doses of AMD on the cleavage of Pr4 to p30 was examined. Table  1 shows the effect of a 1-h pretreatment with different concentrations of AMD on the p30/Pr4 ratio obtained after a subsequent 15-min pulse and 1-h chase. It can be seen that the effect of AMD became noticeable under the conditions of the experiment at 0.1 gg/ml. This concentration of AMD is known to inhibit viral RNA synthesis (10) . The effect of AMD was higher at 1 gg/ml, but no further increase was observed when the concentration was raised to 10 ,ug/ml. This result suggests that the effect of AMD is specific and not due to general cytotoxic effects, which would be expected to increase at higher Cytoplasmic extracts were treated with antiserum to RLV proteins, and the immunoprecipitates were analyzed by SDS-polyacrylamide gel electrophoresis (6 to 12% linear gradient gel). Similar amounts of radioactivity were applied. (Fig. 3) . In this experiment, the cells were pulsed for 15 then examined after immunoprecipitation by anti-RLV antiserum. >The cycloheximide concentration used was in excess of that required for fast and maximal inhibition of protein synthesis. Figure 3B , D, F, and H shows the pattern of viral polypeptides in control cultures after chases for 15 min, 30 min, 1 h, and 3 h, respectively. This is similar to the control chases shown in Fig. 2 . When cycloheximide was added during the chase (Fig. 3C , E, G, and I), the cleavage of Pr4 continued at the same rate as the control for about 30 min before it was drastically reduced. Quantitative measurements of the ratio of p30 to Pr4 from Fig. 3 is shown in Fig. 4B . This result suggests that the cleavage of Pr4 requires the function of a protein(s) that is initially present in excess amounts, if compared on a functional basis to the amount of Pr4 present, but that is quickly depleted. Candidates for such a protein would include a cleavage enzyme or a protein that directs a step in viral assembly that is required for the cleavage of Pr4. However, other more complex mechanisms for the effect of inhibition of protein synthesis on the cleavage of Pr4 are also possible.
In contrast to AMD, cycloheximide also re- duced the cleavage of the precursors polypeptides Prla +b and Pr2a +b (Fig. 3) . Puromycin, at 2 x 10-3 M, had an effect on the cleavage of viral precursor polypeptides, similar to that of cycloheximide, indicating that the effect is due to the inhibition of protein synthesis and not particular to cycloheximide (not shown).
Quantitation of the combined effect of AMD and cycloheximide on the cleavage of Pr4. The effect of AMD on the cleavage of Pr4 could be due either to its direct inhibition of viral RNA synthesis or to the inhibition of a species of mRNA, with a short half-life, which codes for a protein whose function is required for the cleavage of Pr4. To distinguish between these alternatives we have used two approaches, the first of which is to test whether treatment with AMD can increase the inhibition of cleavage of Pr4 caused by cycloheximide used at levels that are high enough to insure maximal inhibition of protein synthesis. Figure  5 shows the amount of Pr4 present in a pulse (A), its reduction after a subsequent chase in duplicate (B, B'), the effect of 200 Ag of cycloheximide per ml added during the chase (C, C'), the effect of 10 ,ug of AMD per ml added 15 min before and during the pulse and chase (D, D'), and the effect of the combined AMD and cycloheximide treatment (E, E') on the extent of cleavage of Pr4 in the chase. Measurements of the ratio of p30 to Pr4 after the different treatments are indicated beneath the different columns. The experiment was done in duplicate to give an idea about the statistical variation in such quantitative measurements. It can be seen that the ratio of p30 to Pr4 was lower after the combined treatment with AMD and cycloheximide than after treatment with either drug alone. This indicates that at least part of the effect of AMD on the cleavage of Pr4 is not due to the inhibition of protein synthesis.
Although the increase in the inhibition of cleavage of Pr4 after the combined treatment with the two drugs over the separate treatments with either drug alone has been reproducible, it seems to be slight. However, it must be noted that simple mathematical additivity should not be expected in such interacting systems. Moreover, examination of the kinetics of cleavage of Pr4 in the presence of the two drugs ( VOL. 19, 1976 on October 26, 2017 by guest http://jvi.asm.org/ strating large additivity in the inhibition of that cleavage after the combined treatment with the drugs.
We have also tested the combined effect of AMD and cycloheximide when AMD was added only during the chase, in order to exclude any possible effect of AMD on the synthesis of virusspecific proteins. In this case, the combined effect of the two drugs was similarly greater than the effect of either drug alone (data not shown).
It must be noted that the rate of cleavage of Pr4 to p30 in control cultures varies somewhat in different experiments. We have found the rate of the cleavage to be affected by the age and confluency of the cell culture. The variation, however, is not large enough to interfere with the statistical significance of the results if comparisons are only made among cultures in one experiment and if the compared cultures are similarly prepared and used within a few hours of each other.
It is to be emphasized, however, that although these results indicate that the mechanisms of action of AMD and cycloheximide are at least partially different, they do not rule out the possibility that part of the effects of these two drugs on the cleavage of Pr4 may be due to a common mechanism. Thus, it is possible that part of the effect of cycloheximide is due to the inhibition of the synthesis or migration of viral RNA. Cycloheximide was found to interfere with total RNA synthesis (14) , the synthesis and processing of rRNA in particular (e.g., ref- erences 14, 53) and the nucleocytoplasmic translocation of RNA (12) in the different systems examined. Similarly, inhibition of RNA synthesis by AMD was found to have an indirect inhibitory effect on the initiation of protein synthesis, which is not a result of the decay of available mRNA (19, 47) .
Effect of the length of pretreatment with AMD on the cleavage of Pr4. A better way of testing whether the effect of AMD on the cleavage of Pr4 is due to indirect inhibition of protein synthesis is to examine the effect of the length of pretreatment with AMD on the cleavage of Pr4 in a subsequent pulse-chase experiment. Thus, if AMD causes a depletion of a protein whose function is required for the cleavage of Pr4, then it is expected that the longer the pretreatment with AMD, the slower the rate obtained for the cleavage of Pr4. lived mRNA, but is more likely due to the direct inhibition by AMD of genomic viral RNA synthesis.
The results also indicate that the mRNA(s) for the cleavage enzyme(s) involved in the maturation of p30 has a relatively long half-life that is comparable to the half-life of the viral mRNA.
If our interpretation of the effect of AMD on the cleavage of Pr4, as being a result of the inhibition by the drug of the synthesis of genomic RNA, is correct, then the above results indicate that there is a pool of genomic viral RNA that is available for catalyzing the cleavage of newly made Pr4 and that this pool is depleted in about 30 min. This period is not likely to be required for AMD to exert its inhibition of RNA synthesis, since AMD is known to act within a few minutes (e.g., reference 44). Note, however, that such a result measures the pool of genomic viral RNA only in terms of its availability for accelerating the cleavage of newly made Pr4 and not in terms of its total amount in the cell.
The above results would indicate, moreover, that the effect of genomic RNA on the cleavage of Pr4 is catalytic rather than obligatory, since cleavage still occurred after 8 h of pretreatment with AMD, at a rate that was constant between 1 to 8 h, after the drug had attained maximal inhibition of viral RNA synthesis.
Effect of AMD on the pattern of synthesis of viral precursor polypeptides. To confirm that AMD did not have any effect on the synthesis of the virus-specific polypeptides, pulselabeling and pulse-chase experiments were performed in the presence and absence of AMD.
The drug (5 ,g/ml) was added to RLV-infected cells 1 h before addition of [35S]methionine. Figure 7 shows a control 15-min pulse labeling (A) and a control 15-min pulse-60-min chase (C). AMD-treated pulse and chase cultures are shown in Fig. 7B and D, respectively. No significant differences were observed in the pulse labeling of AMD-treated (Fig. 7B) and control (Fig. 7A) cultures. In the chase, however, the usual increase in the amount of uncleaved Pr4 was seen in AMD-treated cells. AMD thus did not affect the pattern of synthesis of the viral proteins, but only the rate ofcleavage of Pr4. Occurrence of uncleaved Pr4 in empty particles. We have previously reported the occurrence of uncleaved Pr4 in particles produced by JLS-V5 and JLS-V9, but to a much lesser extent in particles produced by JLS-V16 cells (24) . The fact that Pr4 occurs in virus particles produced naturally by some cell lines indicates that a certain amount of uncleaved Pr4 can be incorporated into mature virions. Since AMD reduced the rate of cleavage of Pr4 in infected cells producing RLV, we tested whether it is possible to cause a buildup of Pr4 in RNAdeficient particles produced by RLV-infected JLS-V16 cells in the presence of AMD. Figure 8 shows the [35S]methionine-labeled proteins of RLV produced in JLS-V16 cells in the presence of 5 ,g of AMD per ml added 4.5 h before labeling and subsequent virus isolation (Fig.  8A) . It is evident that AMD caused a slight accumulation of Pr4 in virus particles relative to control virus (Fig. 8B) . Such a buildup of Pr4 in AMD virus particles was reduced if a period of chase was allowed before virus isolation (not shown). Inspection of the virus-specific proteins in the AMD-treated cells at the time of virus isolation (Fig. 8C) shows a larger proportion of Pr4 than was present in virus produced by these cells. This agrees with the idea, mentioned above, that the relative amount of uncleaved Pr4, in the presence of AMD, is proportional to the period of chase. Thus, because the maturation and budding of virus requires a certain time, the relative amount of uncleaved Pr4 should always be higher in cells than in virus. This also explains why it may sometimes be difficult to observe any increase in Pr4 in AMD virus particles (34) , especially if a period of chase is allowed between labeling and virus isolation. Recent observations have indicated that incubation of Nonidet P-40-disrupted virions at 37°C results in a preferential cleavage of Pr4. This cleavage of Pr4 did not occur if the incubation was carried out in the absence of the detergent (data not shown). These observations can be interpreted to mean that the enzymatic activity required for the cleavage of Pr4 is present in virion preparations, but they also mean that a residual level of Pr4 may not be accessible to the cleavage enzyme(s) in the intact viral particles.
As mentioned above, treatment with AMD greatly reduces or inhibits the synthesis and incorporation of new RNA in subsequently produced viral particles. Concerning the preexisting pool of viral RNA in the cell, Levin et al. (33) found that if the cells were prelabeled with [3H]uridine and then treated with AMD for 2 h, then the viral particles produced lacked the 60 to 708 viral RNA. Similarly, Paskind et al. (40) found that 4 h of pretreatment with AMD greatly depletes the pool of preexisting viral RNA in maturing virions. Thus, the particles whose proteins are shown in Fig. 8A should be mostly, if not completely, devoid of viral RNA, since these particles were newly made after 4 normalized. Figure 9 shows that the [3H]uridine incorporation in viral particles was reduced after AMD treatment. Note that the sH/:5S in the virus was not a reflection of the ratio in the cell debris or the media ( Fig. 9 and legend). This result indicates that it is not likely that cellular RNA quantitatively substitutes for viral RNA in viral particles after the inhibition of genomic viral RNA synthesis by AMD. The RNA present in viral particles after AMD treatment was examined under denatur- ing conditions by electrophoresis in urea-acrylamide-agarose gels (Fig. 10) . The results indicate that whereas virus collected during the first 2 h after AMD treatment contained 35S subunit viral RNA, virus collected at subsequent periods was devoid of this RNA. A similar finding has been previously reported (33) . It is interesting, however, that particles collected after several hours of pretreatment with AMD. contained a broad peak of RNA in the region 15 to 28S. An increase in the 4S RNA content of AMD virus has also been reported (33) . Part of this cellular RNA could be present due to contamination of the viral preparation by cellular debris, whereas another part could be due to the entrapment of cellular material (e.g., ribosomes) inside the virus envelope. However, the possibility exists that some cellular RNA is encapsidated in place of viral RNA. Further work is required to investigate this possibility.
Effect of AMD on the cleavage of Pr4 in JLS-V5 cells. The effect of AMD on the rate of cleavage of Pr4 to p30 was even more noticeable in JLS-V5 than in JLS-V16 cells. JLS-V5 cells produced virus particles that contained a higher amount of uncleaved Pr4 than is present in virus produced by JLS-V16 cells (24) . Also, the rate of cleavage of Pr4 to p30 was noticeably slower in JLS-V5 than in JLS-V16 cells (not shown). (Fig. liB) slowed the cleavage rate of Pr4 in these cells to a greater extent than in similarly treated JLS-V16 cells (Fig. liD) . These results suggest that the increased accumulation of Pr4 in JLS-V5 virus is due to the slower rate of cleavage of this protein intracellularly. A number of factors could cause such an effect, among them a limiting amount of genomic RNA synthesis relative to viral protein synthesis.
However, examination of virus particles produced by JLS-V5 after treatment with AMD did not reveal a drastic accumulation of Pr4, as was seen in the cells (not shown). This suggests that although it is possible to incorporate some uncleaved Pr4 into mature virions, cleavage of Pr4 to p30 to a large extent is probably an essential step in assembly.
Effect of cordycepin and cytochalasin B on the rate of cleavage of Pr4. It was also possible to cause a slowdown of the cleavage of Pr4 by treating cells with 10 ,ug of cytochalasin B per ml (Fig. 12D) or 200 ,ug of cordycepin (3'-deoxyadenosine) per ml (Fig. 12C) . The reason that we tested these two drugs was that, due to some of their known effects, they may interfere with the availability of viral RNA in the cytoplasm. Thus, cytochalasin B causes cell enucleation (42) , which would interfere with the migration of nuclear RNA to the cytoplasm. Cordycepin inhibits poly(A) addition to heterogeneous nuclear RNA and, as a result, intereferes with the processing and migration of that RNA to the cytoplasm (1). This could apply to viral RNA, which is known to contain poly(A) (20, 31, 43) . Cordycepin has been shown to inhibit induction of murine leukemia virus production by 5-iodo-2'-deoxyuridine (54), to depress virus production in virus-producing cell (54) , and to inhibit transformation by murine sarcoma viruses (35, 54) .
However, we have not determined that the effects of cytochalasin B and cordycepin on the cleavage of Pr4 are actually due to their effects on viral RNA synthesis, and it is possible that the effects of these drugs may be due to other cytotoxic effects that these drugs may have. Thus, cordycepin was found to have inhibitory FIG. 10. RNA in viral particles isolated after treatment with AMD. Viral particles were pelleted from the peak fractions of the gradients described in Fig. 9 , suspended in TNE, made 1% in SDS, and extracted with one-fourth the volume of phenol and one-fourth the volume ofchloroform. The RNA in the aqueous layer was precipitated with twice the volume of ethanol, boiled for 1 min, and electrophoresed on 2% polyacrylamide-0.5% agarose urea gels (17) effects on total RNA synthesis (35) and protein synthesis (52) . Further studies are needed to determine the mechanism by which these two drugs interfere with the cleavage of Pr4.
In our studies, treatment with cordycepin also resulted in the appearance of a distinct high-molecular-weight polypeptide that is immunoprecipitable with anti-RLV antisera ( 12C, arrow), which is not usually observed. The identity of this polypeptide is under investigation. DISCUSSION We have shown that AMD significantly reduced the rate of cleavage of intracellular Pr4 to p30 while not affecting the processing of other p30 precursors, such as Pr3 or Prla +b. The results are consistent with the conclusion that AMD exerts its effect on the cleavage of Pr4 by preventing the synthesis of viral genomic RNA, thereby preventing interaction of viral RNA with viral precursor proteins during virus assembly. This interpretation makes it possible to classify the cleavage(s) of Pr4 to p30 as a morphogenetic cleavage (21) and one that is accelerated by interaction with viral RNA.
Pr4, previously called p70, has been detected in mature RLV particles in variable amounts, depending on the cell type producing the virus and the conditions of cell growth (24) . It has been possible to slightly increase the amount of Pr4 in virus preparations produced by RLVinfected JLS-V16 cells by pretreatment of cultures with AMD. However, even long pretreatments (up to 4 h) with AMD did not prevent the almost complete cleavage of Pr4 to p30 in such virus preparations. These results indicate that the interaction with viral genomic RNA is not absolutely required for the cleavage of Pr4 to p30 and supports the idea that the viral RNA only accelerates the rate of cleavage of Pr4 to p30.
Three findings indicate that the effect of AMD on the cleavage of Pr4 is not due to the indirect inhibition of protein synthesis. First, the combined effect of AMD and cycloheximide was greater than the effect of either drug alone. Second, the length of the period ofpretreatment with AMD between 1 and 8 h did not affect the subsequent rate of cleavage of Pr4. Third, AMD did not affect the pattern of viral protein synthesis during pulse-labeling experiments.
Our results agree with the finding reported by other investigators (34, 40) on the presence of two non-equilibrating pools of virus-specific RNA in infected cells: (i) mRNA that functions in translation; and (ii) genomic RNA that is packaged into virions. Because AMD exerts its maximal effect on Pr4 cleavage after treatment for 1 h, we deduce that the pool of viral mRNA, which has a functional half-life of 7 h, is not structurally involved in the interaction which accelerates Pr4 cleavage. This means that it is only the genomic RNA which functions in the enhancement of Pr4 cleavage.
Another point in this study concerns the pool size of genomic viral RNA that is available for accelerating the cleavage of newly made Pr4. Our results indicate that such a pool is rapidly depleted. Thus, whereas less inhibition of cleavage of Pr4 to p30 was observed in cells pretreated with AMD for 15 to 30 min than for 60 min, longer pretreatment with AMD (up to 8 h) had no further inhibitory effect than did a 1- h treatment on the rate of cleavage of Pr4 to p30. However, these results do not measure the rate of depletion of total genomic viral RNA in the cell, which is known to require several hours (about 4) to be depleted (40) . We suggest that this latter pool of genomic viral RNA is already associated with viral proteins and thus cannot affect the cleavage of newly made Pr4.
Our results suggest a long half-life of more than 8 h either for the enzyme(s) involved in the processing of Pr4 or for the mRNA(s) coding for this enzyme(s). The decrease in the rate of cleavage of Pr4 after treatment with inhibitors of protein synthesis may indicate that the enzymes themselves do not have a long half-life. It is possible, however, that inhibitors of protein synthesis interfere with the cleavage of Pr4 by a more complex mechanism that overshadows the direct inhibition of the synthesis of such processing enzymes.
The dependence of the cleavage of precursors to capsid proteins on the interaction with the viral genome is a common pattern in viral assembly (e.g., reference 22, 25, 46) . Such a dependence may stem from the role that cleavage plays in the packaging of the genome. For instance, in T4 the packaging of the viral DNA is accompanied by the cleavage of the core proteins p22 and IPIII (30) . Moreover, the cleavage of the major head protein p23 leads to a structural transformation that results in an expansion of the empty head, which is probably required for the packaging of the DNA (29) . However, a relationship between cleavage and packaging of the genome is not clear in several other systems. For example, in poliovirus the cleavage of the precursor protein vp0 to vp2 and vp4 seems to require the interaction with the viral RNA, since it does not occur in empty capsids. However, this cleavage is not required to bring about the initial association between the viral RNA and the capsid proteins, since RNA-containing provirion particles have been found to contain vp0 (15) . In RLV, as mentioned above, the cleavage of Pr4 to p30, although catalyzed by the genomic RNA, still occurs in the formation of empty cores, thereby suggesting that the role of this cleavage is not in packaging of the genome. However, examination of the cleavage products of Pr4, together with the nature of the influence of genomic RNA on the cleavage of Pr4 that was discussed above, has lead us to a consideration of a model that points to several advantages of having a dependence of the rate of cleavage of Pr4 on the interaction with the genomic RNA. We discuss this model in the section below.
The results presented above have suggested to us that the interaction between the genomic RNA and Pr4 is a prominent step in RLV assembly. Such interaction is likely to result from a direct affinity between Pr4 and the viral RNA, although an indirect interaction is possible. Although direct interaction of purified Pr4 to purified viral RNA has not yet been demonstrated, several recent findings have pointed to the likelihood that such interaction does occur. Thus, Pr4 has been shown to contain two proteins that have affinity for the RNA: plO, which is found in association with the viral RNA (16) and which is rich in arginine and lysine, and a protein that migrates on guanidine hydrochlo-ride agarose columns in the p12 region (L. Karshin, in preparation). (The p12 region in SDSpolyacrylamide gels contains another component, designated pl2E, which migrates on GuHCl agarose columns in the void region. This latter protein contains a methionine-containing tryptic peptide present in pl5E and Pr2a +b, the precursor of the viral gp69/71 [38] .) The other components of Pr4 are p30 and p15 (2; Arlinghaus et al., in press). Sen et al. have demonstrated a strain-specific binding of p12 to genomic RNA (45). Davis et al. have described a basic protein in RLV with a molecular weight of 9,800 that binds to viral RNA and to other heterologous single-stranded RNA and DNA (9) . This protein is though to be the same as the plO that is a component of Pr4. In addition, a 70,000-dalton precursor protein that shares antigenic specificities with RLV p30 has been found in mouse L929 cells, which produce a low level of a C-type virus. This protein exhibits DNA-binding properties and has been isolated by affinity chromatography on single-stranded DNA columns (39) . RLV p30 does not bind to single-stranded DNA under the same conditions (39) . Recently, this precursor protein has also been found to share antigenic determinants with RLV p15, p12, and plO (C. W. Long, personal communication) and is thus very similar to our Pr4. These results suggest that Pr4 probably interacts directly with the RNA. Our results provide evidence for the occurrence of an interaction between the viral RNA and Pr4 in cells. What are the possible advantages of an arrangement in viral assembly in which the cleavage of a precursor polypeptide is affected by the interaction of that precursor with the genomic RNA? To answer this question, we propose the model depicted in Fig. 13 for the CLEAVAGE OF RLV p30 PRECURSOR 1069 assembly of the RLV core. In this model, a "procapsid" structure, consisting of subunits composed of uncleaved Pr4, is formed before interaction with the viral RNA. The formation of this structure is determined only by the specificity of the interactions of the protein subunits. The Pr4 components that probably interact with the RNA, e.g., plO and p12, are depicted on the inside, and the other components, e.g., p30, are on the outside. Entrance of the RNA into this structure results in neutralization of the positive charges of the basic region plO of the molecules in the center and allows the protein subunits to come in a closer proximity and in a more favorable orientation. This facilitates the cleavage of Pr4. Cleavage of Pr4 removes the electrostatic (and possibly the steric) hindrance and allows the p30 subunits to form a more stable association. Cleavage of Pr4 occurs both in the presence of viral RNA, and, at a slower rate, in its absence. Specificity is determined by the interaction of the RNA binding components (e.g., p12 and plO) with the viral RNA. In the absence of the viral RNA, charge neutralization is achieved by counterions or by species of host cell RNA. Incorporation of host cell RNA is not quantitative (i.e., does not result in an RNA/protein ratio similar to the ratio of the normal viral particle), but the extent of incorporation and the species of RNA incorporated are not yet clear. A large portion of Pr4 must be cleaved in order to allow the major capsid protein subunits to assume a close proximity to permit the formation of a stable particle, although a number of uncleaved Pr4 molecules can be incorporated.
In addition to the evidence on the influence of RNA on the cleavage of Pr4, further evidence for this model can be derived from the present Fig. 8; 34 ). Capsid assembly in several viral systems has been shown to be determined mainly by protein-protein interaction (22, 25 (26) . The assembly of DNA viruses, on the other hand, takes place by the formation of an empty capsid which expands in size as packaging of the genome proceeds (23, 29) . A similar arrangement of the basic amino acids on the inside of the capsid structure has been proposed by Matthews and Cole (36) for the capsid of f2 bacteriophage.
Third, since RNA catalyzes the cleavage of Pr4 and since cleavage is, to a large extent, visualized as required for assembly, the model predicts that the formation of RNA-containing cores proceeds faster than the formation of empty cores. This would be of obvious advantage for infectious core formation. Since our results ( Fig. 1) and earlier results by Levin et al. (33) do not indicate a significant reduction in the rate of maturation of virions after treatment with AMD, it may be postulated that core formation is not the limiting step in virus assembly. However, recent results by Levin and Rosenak show a reduction, after treatment of cells with AMD, in the amount of produced virus, as more accurately determined by radioimmune assay of p30 and the level of activity of the reverse transcriptase (34) .
The fourth advantage of the model is that, if there is low affinity between the major core protein and the ribonucleoprotein complex inside it, the genome can then be free to move inside the capsid. Such movement may be important for assuming a structurally favorable arrangement. Structural rearrangement of genomic RNA has been described to occur in a murine sarcoma-leukemia virus after maturation (11) . Moreover, the low affinity of the majoI core protein to the RNA complex would facilitate the uncoating and release of the genome in the next cycle of infection.
In summary, the advantages in this model of having genomic RNA intereact with a precursor to core proteins, rather than to the mature cleaved proteins themselves, are to ensure the existence of an open procapsid structure that can be easily penetrated by the genomic RNA, to make full core formation faster than the formation of empty cores, and to allow encapsidation of the RNA in a coat structure for which it might have low affinity, thereby facilitating its structural rearrangement and subsequent release. Further work is required to test the different aspects of the model.
Finally, our present results suggest that it may be useful to consider a possible role of genomic RNA in the cleavage of viral precursors in other situations. For example, Eisenman et al. (13) reported the presence of a stable precursor-like polypeptide in Rous sarcoma virus-transformed hamster cells and suggested that the lack of cleavage of such a precursor might be due to the absence of the appropriate proteolytic enzymes in the hamster cells. Similarly, the cleavage of precursor polypeptides proceeds slowly in some cell lines, e.g., mouse L929 cells, which produce low levels of C-type particles (39) , or, as we noticed, in C243 cells (5) , which produce noninfectious C-type particles that are devoid of 60 to 70S viral RNA (41) (unpublished observation). If genomic viral RNA plays a role in the cleavage of oncornaviral proteins, then it would be useful to consider the absence of viral genomic RNA, as opposed to viral mRNA, as a possible mechanism that plays a role in the cleavage of the precursor polypeptides.
